These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15876903

  • 1. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
    Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ, Gadde KM, Krishnan KR, Davidson JR.
    J Clin Psychopharmacol; 2005 Jun; 25(3):243-9. PubMed ID: 15876903
    [Abstract] [Full Text] [Related]

  • 2. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH.
    JAMA; 2002 Apr 10; 287(14):1807-14. PubMed ID: 11939866
    [Abstract] [Full Text] [Related]

  • 3. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM, Schmid-Siegel B, Schäfer MR, Lenz G, Saria A, Lee A, Zernig G.
    J Clin Psychiatry; 2006 Feb 10; 67(2):305-9. PubMed ID: 16566628
    [Abstract] [Full Text] [Related]

  • 4. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G, Schüle C, Baghai T, Kieser M.
    Pharmacopsychiatry; 1998 Jun 10; 31 Suppl 1():54-9. PubMed ID: 9684948
    [Abstract] [Full Text] [Related]

  • 5. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC.
    Br J Dermatol; 2000 May 10; 142(5):979-84. PubMed ID: 10809859
    [Abstract] [Full Text] [Related]

  • 6. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
    Chi JD, Franklin M.
    J Chromatogr B Biomed Sci Appl; 1999 Dec 10; 735(2):285-8. PubMed ID: 10670742
    [Abstract] [Full Text] [Related]

  • 7. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 10; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

  • 8. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A, Abrahamyan A, Fujii I, Boubakir Z, Gulder TA, Kutchan TM, Vardapetyan H, Bringmann G, Ebizuka Y, Beerhues L.
    Phytochemistry; 2007 Nov 10; 68(21):2670-7. PubMed ID: 17643455
    [Abstract] [Full Text] [Related]

  • 9. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L, Appendino G, Jakupovic J, Bombardelli E.
    J Nat Prod; 2000 Mar 10; 63(3):412-5. PubMed ID: 10757735
    [Abstract] [Full Text] [Related]

  • 10. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [Abstract] [Full Text] [Related]

  • 11. Undeclared exposure to St. John's Wort in hospitalized patients.
    Martin-Facklam M, Rieger K, Riedel KD, Burhenne J, Walter-Sack I, Haefeli WE.
    Br J Clin Pharmacol; 2004 Oct 01; 58(4):437-41. PubMed ID: 15373938
    [Abstract] [Full Text] [Related]

  • 12. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML, Dvorak C, Chatterjee SS, Klein J.
    J Pharmacol Exp Ther; 2002 May 01; 301(2):714-9. PubMed ID: 11961077
    [Abstract] [Full Text] [Related]

  • 13. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV, Poser W.
    Arch Intern Med; 2000 Sep 11; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract] [Full Text] [Related]

  • 14. Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Cui Y, Gurley B, Ang CY, Leakey J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov 15; 780(1):129-35. PubMed ID: 12383488
    [Abstract] [Full Text] [Related]

  • 15. The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men.
    Lundahl A, Hedeland M, Bondesson U, Knutson L, Lennernäs H.
    Eur J Pharm Sci; 2009 Mar 02; 36(4-5):433-43. PubMed ID: 19073252
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV, Bhattacharya SK, Ghosal S.
    Indian J Exp Biol; 2001 Dec 02; 39(12):1302-4. PubMed ID: 12018529
    [Abstract] [Full Text] [Related]

  • 17. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 02; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 18. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
    Cantoni L, Rozio M, Mangolini A, Hauri L, Caccia S.
    Toxicol Sci; 2003 Sep 02; 75(1):25-30. PubMed ID: 12857935
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.
    Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L.
    CNS Drugs; 2010 Mar 02; 24(3):207-25. PubMed ID: 20155996
    [Abstract] [Full Text] [Related]

  • 20. Hypericin and hyperforin production in St. John's wort in vitro culture: influence of saccharose, polyethylene glycol, methyl jasmonate, and Agrobacterium tumefaciens.
    Pavlík M, Vacek J, Klejdus B, Kuban V.
    J Agric Food Chem; 2007 Jul 25; 55(15):6147-53. PubMed ID: 17608493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.